Electrophysiology Devices – Medical Devices Pipeline Assessment, 2020

Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac catheters and sophisticated computers to generate electrocardiogram (EKG) tracings and electrical measurements with exquisite precision from within the heart chambers. GlobalData's Medical Devices sector report, “Electrophysiology Devices-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Electrophysiology Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Electrophysiology Devices Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Electrophysiology Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Electrophysiology Devices pipeline products.

Review of Recent Developments in the segment / industry

The Electrophysiology Devices Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Electrophysiology Devices- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs

Scope

– Extensive coverage of the Electrophysiology Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Electrophysiology Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abbott Electrophysiology

Ablacon Inc

Apama Medical Inc

AtriCure Inc

Aust Development, LLC

Baylor College of Medicine

Ben-Gurion University of the Negev

Berlin Heals GmbH

Biosense Webster Inc

BioSig Technologies Inc

BioTex Inc

Boston Scientific Corp

Cardima, Inc. (Inactive)

CardioNova Ltd

CathEffects LLC

CathRx Ltd

CathVision Aps

Cibiem Inc

ClearPoint Neuro Inc

Columbia University

Cordis Corp

CoreMap Inc

CoRepair, Inc

CPSI Biotech

CryoTherapeutics Gmbh

CyberHeart Inc

EP Solutions SA

EPD Solutions Ltd

Epicardial Technologies Inc (Inactive)

EPMap-System GmbH & Co KG

Eximo Medical Ltd

Farapulse Inc

FocusStart LLC

Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon

Hansen Medical Inc (Inactive)

Hyblate Medical

Imricor Medical Systems Inc

Interventional Imaging, Inc.

Iowa Approach Inc.

Johns Hopkins University

King's College London

Maestro Heart SA

MC10 Inc

Medlumics SL

Medtronic Plc

MedWaves Inc

MicroPort Scientific Corp

Northwestern University

Novasentis Inc

Philips Healthcare

S4 Medical Corp

SCR, Inc.

Seattle Children's Hospital

Seoul National University Hospital

St. Jude Medical LLC

Stanford University

Stereotaxis Inc

The Cleveland Clinic Foundation

University of Arkansas at Little Rock

University of Auckland

University of Maryland

University of Michigan

University of Rochester

University of Texas Medical Branch at Galveston

University of Utah

Vanderbilt University

Vimecon GmbH

Viscardia Inc

Vivonics Inc

Voyage Medical (Inactive)

Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 13

2 Introduction 14

2.1 Electrophysiology Devices Overview 14

3 Products under Development 16

3.1 Electrophysiology Devices – Pipeline Products by Stage of Development 16

3.2 Electrophysiology Devices – Pipeline Products by Segment 17

3.3 Electrophysiology Devices – Pipeline Products by Territory 18

3.4 Electrophysiology Devices – Pipeline Products by Regulatory Path 19

3.5 Electrophysiology Devices – Pipeline Products by Estimated Approval Date 20

3.6 Electrophysiology Devices – Ongoing Clinical Trials 21

4 Electrophysiology Devices – Pipeline Products under Development by Companies 22

4.1 Electrophysiology Devices Companies – Pipeline Products by Stage of Development 22

4.2 Electrophysiology Devices – Pipeline Products by Stage of Development 25

5 Electrophysiology Devices Companies and Product Overview 28

5.1 Abbott Electrophysiology Company Overview 28

5.1.1 Abbott Electrophysiology Pipeline Products & Ongoing Clinical Trials Overview 28

5.2 Ablacon Inc Company Overview 31

5.2.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.3 Apama Medical Inc Company Overview 32

5.3.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.4 AtriCure Inc Company Overview 33

5.4.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.5 Aust Development, LLC Company Overview 34

5.5.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 34

5.6 Baylor College of Medicine Company Overview 35

5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 35

5.7 Ben-Gurion University of the Negev Company Overview 36

5.7.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 Berlin Heals GmbH Company Overview 37

5.8.1 Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

5.9 Biosense Webster Inc Company Overview 38

5.9.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 BioSig Technologies Inc Company Overview 46

5.10.1 BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.11 BioTex Inc Company Overview 52

5.11.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.12 Boston Scientific Corp Company Overview 53

5.12.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 53

5.13 Cardima, Inc. (Inactive) Company Overview 62

5.13.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

5.14 CardioNova Ltd Company Overview 64

5.14.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.15 CathEffects LLC Company Overview 65

5.15.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.16 CathRx Ltd Company Overview 66

5.16.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.17 CathVision Aps Company Overview 69

5.17.1 CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview 69

5.18 Cibiem Inc Company Overview 70

5.18.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.19 ClearPoint Neuro Inc Company Overview 73

5.19.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 Columbia University Company Overview 75

5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75

5.21 Cordis Corp Company Overview 76

5.21.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 CoreMap Inc Company Overview 78

5.22.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.23 CoRepair, Inc Company Overview 79

5.23.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.24 CPSI Biotech Company Overview 80

5.24.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 80

5.25 CryoTherapeutics Gmbh Company Overview 82

5.25.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 82

5.26 CyberHeart Inc Company Overview 83

5.26.1 CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.27 EP Solutions SA Company Overview 87

5.27.1 EP Solutions SA Pipeline Products & Ongoing Clinical Trials Overview 87

5.28 EPD Solutions Ltd Company Overview 88

5.28.1 EPD Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

5.29 Epicardial Technologies Inc (Inactive) Company Overview 91

5.29.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 91

5.30 EPMap-System GmbH & Co KG Company Overview 92

5.30.1 EPMap-System GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 92

5.31 Eximo Medical Ltd Company Overview 94

5.31.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

5.32 Farapulse Inc Company Overview 95

5.32.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.33 FocusStart LLC Company Overview 101

5.33.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 101

5.34 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 102

5.34.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 102

5.35 Hansen Medical Inc (Inactive) Company Overview 103

5.35.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103

5.36 Hyblate Medical Company Overview 106

5.36.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 106

5.37 Imricor Medical Systems Inc Company Overview 107

5.37.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.38 Interventional Imaging, Inc. Company Overview 109

5.38.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109

5.39 Iowa Approach Inc. Company Overview 110

5.39.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 110

5.40 Johns Hopkins University Company Overview 113

5.40.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 113

5.41 King's College London Company Overview 114

5.41.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 114

5.42 Maestro Heart SA Company Overview 115

5.42.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 115

5.43 MC10 Inc Company Overview 116

5.43.1 MC10 Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.44 Medlumics SL Company Overview 117

5.44.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 117

5.45 Medtronic Plc Company Overview 118

5.45.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 118

5.46 MedWaves Inc Company Overview 122

5.46.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 122

5.47 MicroPort Scientific Corp Company Overview 123

5.47.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 123

5.48 Northwestern University Company Overview 127

5.48.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 127

5.49 Novasentis Inc Company Overview 129

5.49.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.50 Philips Healthcare Company Overview 130

5.50.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 130

5.51 S4 Medical Corp Company Overview 131

5.51.1 S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 131

5.52 SCR, Inc. Company Overview 132

5.52.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132

5.53 Seattle Children's Hospital Company Overview 133

5.53.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 133

5.54 Seoul National University Hospital Company Overview 134

5.54.1 Seoul National University Hospital Pipeline Products & Ongoing Clinical Trials Overview 134

5.55 St. Jude Medical LLC Company Overview 135

5.55.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 135

5.56 Stanford University Company Overview 139

5.56.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 139

5.57 Stereotaxis Inc Company Overview 140

5.57.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.58 The Cleveland Clinic Foundation Company Overview 143

5.58.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 143

5.59 University of Arkansas at Little Rock Company Overview 144

5.59.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 144

5.60 University of Auckland Company Overview 145

5.60.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 145

5.61 University of Maryland Company Overview 146

5.61.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 146

5.62 University of Michigan Company Overview 147

5.62.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 147

5.63 University of Rochester Company Overview 148

5.63.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 148

5.64 University of Texas Medical Branch at Galveston Company Overview 149

5.64.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 149

5.65 University of Utah Company Overview 151

5.65.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 151

5.66 Vanderbilt University Company Overview 152

5.66.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 152

5.67 Vimecon GmbH Company Overview 153

5.67.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 153

5.68 Viscardia Inc Company Overview 154

5.68.1 Viscardia Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.69 Vivonics Inc Company Overview 155

5.69.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 155

5.70 Voyage Medical (Inactive) Company Overview 156

5.70.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 156

6 Electrophysiology Devices- Recent Developments 157

6.1 Sep 22, 2020: Laurel Bridge Software and Ultromics partnership increases accessibility to AI solutions for echocardiography 157

6.2 Sep 17, 2020: CIRSE 2020: New clinical data support use of 4-french devices for ambulatory pad treatment 157

6.3 Aug 27, 2020: AI image guided therapy systems reduce radiation exposure during cardiac device implantation 158

6.4 Aug 26, 2020: Cleveland Clinic reaches milestones in heart transplantation and lung transplantation 158

6.5 Aug 04, 2020: Artificial intelligence-enhanced ECGs may speed heart failure diagnosis and treatment 159

6.6 Aug 04, 2020: Imricor announces first sales collaboration with Philips 160

6.7 Jul 23, 2020: PolyA-miner accurately assesses the effect of alternative polyadenylation on gene expression 161

6.8 Jul 13, 2020: Benefits of Stereotaxis robotic technology in COVID-19 patient highlighted in publication 162

6.9 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility 163

6.10 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical 163

6.11 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 164

6.12 May 19, 2020: Cathvision completes new investment round of a total 13M Euro 165

6.13 May 15, 2020: Microport orthopedics group brings in new strategic investors 165

6.14 May 07, 2020: FARAPULSE's pioneering clinical results link compelling long-term outcomes to established safety and lesion durability data 166

6.15 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 167

6.16 Mar 09, 2020: VisCardia announces completion of Its VisONE heart failure pilot study 168

6.17 Mar 06, 2020: Stereotaxis earns FDA clearance and announces U.S. launch of Genesis robotic magnetic navigation system 169

6.18 Mar 03, 2020: BioSig to webcast its presentation at the Cowen and Company’s 40th Annual Health Care Conference 169

6.19 Feb 26, 2020: Harvard Bioscience announces fourth quarter 2019 financial results 170

6.20 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019 171

6.21 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 171

6.22 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 172

6.23 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 173

6.24 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 173

6.25 Feb 20, 2020: Integer Holdings reports results for fourth quarter and full year 2019 174

6.26 Feb 19, 2020: BioSig completes 100th patient case with PURE EP System 175

6.27 Feb 18, 2020: Medtronic reports third quarter financial results 2020 176

6.28 Feb 12, 2020: ClearPoint Neuro reports 53% increase in 2019 revenue 178

6.29 Feb 05, 2020: Imricor announces first cases successfully performed at Heart Center Dresden 180

6.30 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 181

6.31 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 182

6.32 Feb 02, 2020: First cases successfully performed at Heart Center Dresden 184

6.33 Jan 30, 2020: FARAPULSE extensively showcased at leading AF Symposium 185

6.34 Jan 28, 2020: Imricor receives CE Mark approval for Vision-MR Ablation Catheter 186

6.35 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 187

6.36 Jan 23, 2020: Study finds SureFlex Steerable Guiding Sheath has greater contact force stability for Radiofrequency Ablations 188

6.37 Jan 23, 2020: Vulnerability disclosure regarding GE Healthcare monitoring products 188

6.38 Jan 23, 2020: GE Healthcare to move as many as 250 jobs from Wisconsin 189

6.39 Jan 21, 2020: BioSig to present at the 25th Annual International AF Symposium 189

6.40 Jan 16, 2020: BioSig to commence patient cases at Mayo Clinic 190

6.41 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 190

6.42 Jan 14, 2020: BioSig awarded additional US patent claims for its PURE EP System 191

6.43 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 191

6.44 Jan 13, 2020: MRI Interventions to change corporate name to ClearPoint Neuro 192

6.45 Jan 07, 2020: Cleveland Clinic appoints Lara Jehi, M.D., Chief Research Information Officer 193

6.46 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 194

6.47 Dec 19, 2019: Affera announces world's first successful focal pulsed field ablation in patients 194

6.48 Dec 16, 2019: First patients treated in new robotic arrhythmia care program at Overland Park Regional Medical Center 195

6.49 Dec 16, 2019: Mr Meng joins Uscom board 196

6.50 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 197

6.51 Dec 04, 2019: AtriCure names two industry veterans to Board of Directors 197

6.52 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 198

6.53 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 199

6.54 Dec 03, 2019: New Uscom US Sales and Marketing Expansion 199

6.55 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference 200

6.56 Nov 21, 2019: BioSig commences clinical trial enrollment for PURE EP System 201

6.57 Nov 21, 2019: Cleveland Clinic names James Merlino, M.D., chief clinical transformation officer 201

6.58 Nov 20, 2019: Former Cleveland Clinic CEO Toby Cosgrove, MD, joins InnovaHealth Partners as Senior Advisor 202

6.59 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 202

6.60 Nov 18, 2019: Freudenberg Medical launches wave of product and process innovations 205

6.61 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 206

6.62 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 206

6.63 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 207

6.64 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 208

6.65 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 210

6.66 Nov 06, 2019: CardioFocus treats first patients with HeartLight endoscopic ablation system in France 210

6.67 Nov 05, 2019: Stereotaxis and inHEART combine robotic precision and advanced preoperative 3D mapping to treat cardiac arrhythmias 211

6.68 Nov 05, 2019: Harvard Bioscience announces third quarter financial results 211

6.69 Nov 01, 2019: Baylis launches 2F EPstar catheter in North America 213

6.70 Nov 01, 2019: Stereotaxis and ADAS 3D combine robotic precision and advanced preoperative substrate mapping to treat cardiac arrhythmias 213

6.71 Oct 31, 2019: Harvard Bioscience Announces Executive Appointment 214

6.72 Oct 31, 2019: CathVision Rrceives competitive EU Grant 214

6.73 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 215

6.74 Oct 30, 2019: AtriCure reports third quarter 2019 financial results 218

6.75 Oct 29, 2019: CardioFocus treats first patients with HeartLight Endoscopic Ablation System In France 218

6.76 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 219

6.77 Oct 23, 2019: Uscom: Quarterly Report at 30th September 2019 221

6.78 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 222

6.79 Oct 21, 2019: Harvard Bioscience announces Executive appointment 223

6.80 Oct 10, 2019: BioSig to participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy 223

7 Appendix 225

7.1 Methodology 225

7.2 About GlobalData 229

7.3 Contact Us 229

List of Tables

Table 1: Electrophysiology Devices – Pipeline Products by Stage of Development 16

Table 2: Electrophysiology Devices – Pipeline Products by Segment 17

Table 3: Electrophysiology Devices – Pipeline Products by Territory 18

Table 4: Electrophysiology Devices – Pipeline Products by Regulatory Path 19

Table 5: Electrophysiology Devices – Pipeline Products by Estimated Approval Date 20

Table 6: Electrophysiology Devices – Ongoing Clinical Trials 21

Table 7: Electrophysiology Devices Companies – Pipeline Products by Stage of Development 22

Table 8: Electrophysiology Devices – Pipeline Products by Stage of Development 25

Table 9: Abbott Electrophysiology Pipeline Products & Ongoing Clinical Trials Overview 28

Table 10: TactiFlex SE – Product Status 28

Table 11: TactiFlex SE – Product Description 28

Table 12: Abbott Electrophysiology – Ongoing Clinical Trials Overview 29

Table 13: TactiFlex SE – Safety and Effectiveness of TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE) for the Treatment of Drug Refractory, Symptomatic, Paroxysmal Atrial Fibrillation 30

Table 14: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 15: Ablasense – Product Status 31

Table 16: Ablasense – Product Description 31

Table 17: Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 18: LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Status 32

Table 19: LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Description 32

Table 20: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 21: Next Generation RF Generator – Product Status 33

Table 22: Next Generation RF Generator – Product Description 33

Table 23: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 34

Table 24: Endovascular Cardiac Optical Mapping Device – Product Status 34

Table 25: Endovascular Cardiac Optical Mapping Device – Product Description 34

Table 26: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 35

Table 27: Catheter-Based Electrophysiological Imaging System – Product Status 35

Table 28: Catheter-Based Electrophysiological Imaging System – Product Description 35

Table 29: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 36

Table 30: Excitation Wave Cancellation Device – Product Status 36

Table 31: Excitation Wave Cancellation Device – Product Description 36

Table 32: Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

Table 33: Berlin Heals Cardiac Microcurrent Therapy Device – Product Status 37

Table 34: Berlin Heals Cardiac Microcurrent Therapy Device – Product Description 37

Table 35: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 36: CARTO 4 – Product Status 38

Table 37: CARTO 4 – Product Description 38

Table 38: CARTO SMARTTOUCH 5D Catheter – Product Status 39

Table 39: CARTO SMARTTOUCH 5D Catheter – Product Description 39

Table 40: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter – Product Status 39

Table 41: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter – Product Description 40

Table 42: Navigation Guided Deflectable Sheath – Product Status 40

Table 43: Navigation Guided Deflectable Sheath – Product Description 40

Table 44: THERMOCOOL SMARTTOUCH SF-5D Catheter – Product Status 41

Table 45: THERMOCOOL SMARTTOUCH SF-5D Catheter – Product Description 41

Table 46: Biosense Webster Inc – Ongoing Clinical Trials Overview 42

Table 47: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter – Safety and Effectiveness Evaluation of the Multi-electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation: STELLAR 43

Table 48: Navigation Guided Deflectable Sheath – Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture for Cryoballoon Ablation 44

Table 49: THERMOCOOL SMARTTOUCH SF-5D Catheter – Acute Performance Evaluation of the QDOT Micro Catheter Used with nGEN Generator in Treatment of Patients with Atrial Fibrillation 45

Table 50: THERMOCOOL SMARTTOUCH SF-5D Catheter – Evaluation of QDOT Micro Catheter for Pulmonary Vein Isolation (PVI) in Subjects with PAF 45

Table 51: BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 52: PURE EP System – Product Status 46

Table 53: PURE EP System – Product Description 46

Table 54: PURE EP Version 2.0 – Product Status 47

Table 55: PURE EP Version 2.0 – Product Description 47

Table 56: PURE EP Version 3.0 – Product Status 47

Table 57: PURE EP Version 3.0 – Product Description 48

Table 58: BioSig Technologies Inc – Ongoing Clinical Trials Overview 49

Table 59: PURE EP System – Validation of Safety and efficacy of the PURE EP System During Mapping and Ablation Procedures in Cardiac EP lab 50

Table 60: PURE EP Version 2.0 – Novel Cardiac Signal Processing System for Electrophysiology Procedures 51

Table 61: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Table 62: Cooled Tip Catheter – Product Status 52

Table 63: Cooled Tip Catheter – Product Description 52

Table 64: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 53

Table 65: Force Sensing Afib Catheter – Product Status 53

Table 66: Force Sensing Afib Catheter – Product Description 54

Table 67: Intellanav Stablepoint – Product Status 54

Table 68: Intellanav Stablepoint – Product Description 54

Table 69: LabSystem PRO NextGen – Product Status 55

Table 70: LabSystem PRO NextGen – Product Description 55

Table 71: Lesion Assessment Device – Product Status 55

Table 72: Lesion Assessment Device – Product Description 56

Table 73: Next Generation Blazer Catheter – Product Status 56

Table 74: Next Generation Blazer Catheter – Product Description 56

Table 75: Next Generation IntellaTip Catheter – Product Status 56

Table 76: Next Generation IntellaTip Catheter – Product Description 57

Table 77: OI System – Product Status 57

Table 78: OI System – Product Description 57

Table 79: POLARx Next Generation Catheter – Product Status 58

Table 80: POLARx Next Generation Catheter – Product Description 58

Table 81: POLARx Single Shot Cryoballoon – Product Status 58

Table 82: POLARx Single Shot Cryoballoon – Product Description 58

Table 83: Rhythmia 5.0 – Product Status 59

Table 84: Rhythmia 5.0 – Product Description 59

Table 85: Boston Scientific Corp – Ongoing Clinical Trials Overview 60

Table 86: POLARx Single Shot Cryoballoon – POLARx Cardiac Cryoablation System Post Market Clinical Follow-up Study 61

Table 87: POLARx Single Shot Cryoballoon – Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation 61

Table 88: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

Table 89: CADENCE EPL – Product Status 62

Table 90: CADENCE EPL – Product Description 62

Table 91: EP Ablation System – Product Status 62

Table 92: EP Ablation System – Product Description 63

Table 93: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Table 94: Electrophysiology Catheter – Atrial Fibrillation – Product Status 64

Table 95: Electrophysiology Catheter – Atrial Fibrillation – Product Description 64

Table 96: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 65

Table 97: Desai VectorCathRF1 Mapping And Ablation Catheter – Product Status 65

Table 98: Desai VectorCathRF1 Mapping And Ablation Catheter – Product Description 65

Table 99: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Table 100: CathRx 4mm Therapeutic Catheter – Product Status 66

Table 101: CathRx 4mm Therapeutic Catheter – Product Description 66

Table 102: CathRx 8mm Therapeutic Catheter – Product Status 67

Table 103: CathRx 8mm Therapeutic Catheter – Product Description 67

Table 104: Khelix Irrigated Ablation EP Catheter – Product Status 67

Table 105: Khelix Irrigated Ablation EP Catheter – Product Description 68

Table 106: Khelix Non-Irrigated Ablation EP Catheter – Product Status 68

Table 107: Khelix Non-Irrigated Ablation EP Catheter – Product Description 68

Table 108: CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview 69

Table 109: CathVision Cube – Product Status 69

Table 110: CathVision Cube – Product Description 69

Table 111: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Table 112: Catheter-Based Carotid Body Ablation System – Product Status 70

Table 113: Catheter-Based Carotid Body Ablation System – Product Description 70

Table 114: Cibiem Inc – Ongoing Clinical Trials Overview 71

Table 115: Catheter-Based Carotid Body Ablation System – First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study 72

Table 116: ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Table 117: ClearTrace Cardiac Intervention System – Product Status 73

Table 118: ClearTrace Cardiac Intervention System – Product Description 74

Table 119: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 75

Table 120: Optically-Integrated RFA Catheter – Product Status 75

Table 121: Optically-Integrated RFA Catheter – Product Description 75

Table 122: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 76

Table 123: EP Contact Force Sensing Catheter Enabled By CARTO 3 – Product Status 76

Table 124: EP Contact Force Sensing Catheter Enabled By CARTO 3 – Product Description 76

Table 125: EP Lesion Assessment Device – Product Status 77

Table 126: EP Lesion Assessment Device – Product Description 77

Table 127: CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Table 128: Electrophysiology Mapping System – Atrial Fibrillation – Product Status 78

Table 129: Electrophysiology Mapping System – Atrial Fibrillation – Product Description 78

Table 130: CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Table 131: Radiofrequency Device – Product Status 79

Table 132: Radiofrequency Device – Product Description 79

Table 133: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 80

Table 134: FrostBite – Product Status 80

Table 135: FrostBite – Product Description 81

Table 136: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 82

Table 137: Cryotherapy System – Coronary Artery Disease – Product Status 82

Table 138: Cryotherapy System – Coronary Artery Disease – Product Description 82

Table 139: CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Table 140: CyberHeart System – Product Status 83

Table 141: CyberHeart System – Product Description 84

Table 142: CyberHeart Inc – Ongoing Clinical Trials Overview 85

Table 143: CyberHeart System – CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients with Refractory Ventricular Tachycardia 86

Table 144: EP Solutions SA Pipeline Products & Ongoing Clinical Trials Overview 87

Table 145: Second Generation AMYCARD System – Product Status 87

Table 146: Second Generation AMYCARD System – Product Description 87

Table 147: EPD Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

Table 148: KODEX-EPD System – Balloon Visualization – Product Status 88

Table 149: KODEX-EPD System – Balloon Visualization – Product Description 88

Table 150: EPD Solutions Ltd – Ongoing Clinical Trials Overview 89

Table 151: KODEX-EPD System – Balloon Visualization – PROOF: Evaluating the Performance of the KODEX-EPD Cryoballoon Occlusion Feature in Patients With Atrium Fibrillation 90

Table 152: KODEX-EPD System – Balloon Visualization – Prospective Procedural Data Collection for Continuous Improvement of the KODEX – EPD System Performance 90

Table 153: Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 91

Table 154: Epicardial Access Device – Product Status 91

Table 155: Epicardial Access Device – Product Description 91

Table 156: EPMap-System GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 92

Table 157: EP Map System – Product Status 92

Table 158: EP Map System – Product Description 93

Table 159: Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

Table 160: B-Laser – CAD – Product Status 94

Table 161: B-Laser – CAD – Product Description 94

Table 162: Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 95

Table 163: Endo FARAFLEX – Product Status 95

Table 164: Endo FARAFLEX – Product Description 95

Table 165: Endo Farapoint – Product Status 96

Table 166: Endo Farapoint – Product Description 96

Table 167: Endo Farawave – Product Status 96

Table 168: Endo Farawave – Product Description 97

Table 169: Epi Faraone – Product Status 97

Table 170: Epi Faraone – Product Description 97

Table 171: Farastar – Product Status 98

Table 172: Farastar – Product Description 98

Table 173: Farapulse Inc – Ongoing Clinical Trials Overview 99

Table 174: Endo Farawave – A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation: PEFCAT 100

Table 175: Endo Farawave – Feasibility Study of the FARAPULSE Endocardial Ablation System in the Treatment of Persistent Atrial Fibrillation: PersAFOne 100

Table 176: Endo Farawave – PEFCAT II: Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation 100

Table 177: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 101

Table 178: Anti-coagulum Cardiac Ablation Catheter – Product Status 101

Table 179: Anti-coagulum Cardiac Ablation Catheter – Product Description 101

Table 180: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 102

Table 181: Fibrillation Catheter – Product Status 102

Table 182: Fibrillation Catheter – Product Description 102

Table 183: Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103

Table 184: Sensei Robotic Catheter System – Percutaneous Aortic Valve Replacement – Product Status 103

Table 185: Sensei Robotic Catheter System – Percutaneous Aortic Valve Replacement – Product Description 103

Table 186: Sensei Robotic Catheter System – PFO Closure – Product Status 104

Table 187: Sensei Robotic Catheter System – PFO Closure – Product Description 104

Table 188: Sensei X Robotic Catheter System – Atrial Fibrillation – Product Status 104

Table 189: Sensei X Robotic Catheter System – Atrial Fibrillation – Product Description 105

Table 190: Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 106

Table 191: Hybrid Ablation Catheter – Product Status 106

Table 192: Hybrid Ablation Catheter – Product Description 106

Table 193: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 107

Table 194: Advantage-MR EP Recorder/Stimulator System – Product Status 107

Table 195: Advantage-MR EP Recorder/Stimulator System – Product Description 108

Table 196: Vision MR Ablation Catheter – Product Status 108

Table 197: Vision MR Ablation Catheter – Product Description 108

Table 198: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109

Table 199: Atrial Fibrillation Catheter – Product Status 109

Table 200: Atrial Fibrillation Catheter – Product Description 109

Table 201: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 110

Table 202: MaPP-CS – Product Status 110

Table 203: MaPP-CS – Product Description 110

Table 204: ROF-AC – Product Status 111

Table 205: ROF-AC – Product Description 111

Table 206: ROF-AS – Product Status 111

Table 207: ROF-AS – Product Description 112

Table 208: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 113

Table 209: RF Ablation Lesion Assessment System – Product Status 113

Table 210: RF Ablation Lesion Assessment System – Product Description 113

Table 211: King's College London Pipeline Products & Ongoing Clinical Trials Overview 114

Table 212: Steerable Catheter – Product Status 114

Table 213: Steerable Catheter – Product Description 114

Table 214: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 115

Table 215: Maestro-AF Catheter System – Product Status 115

Table 216: Maestro-AF Catheter System – Product Description 115

Table 217: MC10 Inc Pipeline Products & Ongoing Clinical Trials Overview 116

Table 218: Sensor-Covered Cardiac Catheter – Product Status 116

Table 219: Sensor-Covered Cardiac Catheter – Product Description 116

Table 220: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 117

Table 221: AblaView – Product Status 117

Table 222: AblaView – Product Description 117

Table 223: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 118

Table 224: DiamondTemp Ablation System – Product Status 118

Table 225: DiamondTemp Ablation System – Product Description 119

Table 226: Medtronic Plc – Ongoing Clinical Trials Overview 120

Table 227: DiamondTemp Ablation System – A Prospective Clinical Evaluation of the DiamondTemp System for the Treatment of Persistent Atrial Fibrillation 121

Table 228: DiamondTemp Ablation System – A Prospective Single Arm Clinical Evaluation for the Characterization of the Safety Profile of the DiamondTemp System for Fast Treatment of Patients with Atrial Fibrillation 121

Table 229: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 122

Table 230: Arrhythmia Catheters – Product Status 122

Table 231: Arrhythmia Catheters – Product Description 122

Table 232: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 123

Table 233: Circular Ablation Catheter – Product Status 123

Table 234: Circular Ablation Catheter – Product Description 123

Table 235: Circular Diagnostic Catheter – Product Status 124

Table 236: Circular Diagnostic Catheter – Product Description 124

Table 237: Introducer Needle – Product Status 124

Table 238: Introducer Needle – Product Description 125

Table 239: Variable Loop – Product Status 125

Table 240: Variable Loop – Product Description 125

Table 241: Voyager Irrigated RF Ablation Catheter – Product Status 126

Table 242: Voyager Irrigated RF Ablation Catheter – Product Description 126

Table 243: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 127

Table 244: AF Electrogram Analysis Software – Product Status 127

Table 245: AF Electrogram Analysis Software – Product Description 127

Table 246: Cardiac Catheter – Product Status 128

Table 247: Cardiac Catheter – Product Description 128

Table 248: Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 129

Table 249: Electroactive Polymer Based Steerable Catheter – Product Status 129

Table 250: Electroactive Polymer Based Steerable Catheter – Product Description 129

Table 251: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 130

Table 252: Integrated X-Ray And Robotic Catheter System – Product Status 130

Table 253: Integrated X-Ray And Robotic Catheter System – Product Description 130

Table 254: S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 131

Table 255: Sotera – Atrial Fibrillation Device – Product Status 131

Table 256: Sotera – Atrial Fibrillation Device – Product Description 131

Table 257: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132

Table 258: Atrial Fibrillation Device – Product Status 132

Table 259: Atrial Fibrillation Device – Product Description 132

Table 260: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 133

Table 261: Ablation Catheter – Heart Arrhythmia – Product Status 133

Table 262: Ablation Catheter – Heart Arrhythmia – Product Description 133

Table 263: Seoul National University Hospital Pipeline Products & Ongoing Clinical Trials Overview 134

Table 264: Cardiac Stimulator – Product Status 134

Table 265: Cardiac Stimulator – Product Description 134

Table 266: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 135

Table 267: All-in-one Catheter Ablation System – Product Status 135

Table 268: All-in-one Catheter Ablation System – Product Description 135

Table 269: FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Status 136

Table 270: FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Description 136

Table 271: St. Jude Medical LLC – Ongoing Clinical Trials Overview 137

Table 272: FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Flexability Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study 138

Table 273: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 139

Table 274: Cardiac-Mapping Catheter – Product Status 139

Table 275: Cardiac-Mapping Catheter – Product Description 139

Table 276: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 140

Table 277: Magnetic Ablation Catheter – Product Status 140

Table 278: Magnetic Ablation Catheter – Product Description 140

Table 279: Next Generation Irrigated Magnetic Catheter – Product Status 141

Table 280: Next Generation Irrigated Magnetic Catheter – Product Description 141

Table 281: Robotic Magnetic Navigation System – Pulmonary Hypertension – Product Status 141

Table 282: Robotic Magnetic Navigation System – Pulmonary Hypertension – Product Description 142

Table 283: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 143

Table 284: EP Mapping Catheter – Product Status 143

Table 285: EP Mapping Catheter – Product Description 143

Table 286: University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 144

Table 287: Robotic Catheter – Product Status 144

Table 288: Robotic Catheter – Product Description 144

Table 289: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 145

Table 290: 3D Heart Mapping Device – Product Status 145

Table 291: 3D Heart Mapping Device – Product Description 145

Table 292: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 146

Table 293: Steerable Actuated Catheter – Product Status 146

Table 294: Steerable Actuated Catheter – Product Description 146

Table 295: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 147

Table 296: Non-Contact Mapping Catheter – Product Status 147

Table 297: Non-Contact Mapping Catheter – Product Description 147

Table 298: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 148

Table 299: RF Ablation Catheter – Product Status 148

Table 300: RF Ablation Catheter – Product Description 148

Table 301: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 149

Table 302: Ablation Catheter – Product Status 149

Table 303: Ablation Catheter – Product Description 150

Table 304: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 151

Table 305: Cardiac Tissue Imaging Catheter – Product Status 151

Table 306: Cardiac Tissue Imaging Catheter – Product Description 151

Table 307: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 152

Table 308: Temperature Controlled Catheter – Product Status 152

Table 309: Temperature Controlled Catheter – Product Description 152

Table 310: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 153

Table 311: Vimecon Laser CAI Catheter – Product Status 153

Table 312: Vimecon Laser CAI Catheter – Product Description 153

Table 313: Viscardia Inc Pipeline Products & Ongoing Clinical Trials Overview 154

Table 314: VisONE System – Product Status 154

Table 315: VisONE System – Product Description 154

Table 316: Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 155

Table 317: Catheter Guidance System – Product Status 155

Table 318: Catheter Guidance System – Product Description 155

Table 319: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 156

Table 320: IRIS Ablation System – Product Status 156

Table 321: IRIS Ablation System – Product Description 156

List of Figures

Figure 1: Electrophysiology Devices – Pipeline Products by Stage of Development 16

Figure 2: Electrophysiology Devices – Pipeline Products by Segment 17

Figure 3: Electrophysiology Devices – Pipeline Products by Territory 18

Figure 4: Electrophysiology Devices – Pipeline Products by Regulatory Path 19

Figure 5: Electrophysiology Devices – Pipeline Products by Estimated Approval Date 20

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports